4,770 followers
RT @ethanjweiss: New Cochrane Review on Ruxolitinib in myelofibrosis. It is not favorable... https://t.co/cnXJhmk7eN
RT @ethanjweiss: New Cochrane Review on Ruxolitinib in myelofibrosis. It is not favorable... https://t.co/cnXJhmk7eN
RT @ethanjweiss: New Cochrane Review on Ruxolitinib in myelofibrosis. It is not favorable... https://t.co/cnXJhmk7eN
New Cochrane Review on Ruxolitinib in myelofibrosis. It is not favorable... https://t.co/cnXJhmk7eN
Cochrane: Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis http://t.co/SdnkAcPujv